Study on the Management System of OTC Drug in Taiwan Are a of China Based on Consumer Guidance Perspective / 中国药房

OBJECTIVE： To provide reference for the improvement of OTC drug management system in mainland China. METHODS： By analyzing the classification， registration management， conversion procedures and supporting measures， instructions and packaging management of OTC drugs in Taiwan area of China， and considering the current situation and problems of OTC drug management in mainland China， suggestions for improving OTC drug management system in mainland China were put forward. RESULTS & CONCLUSIONS： OTC drugs of Taiwan area could be divided into drugs instructed by physicians and pharmacists （hereinafter referred to as “instructed drugs”） as well as patent drugs. The registration management of instructed drugs was implemented in accordance with the Criteria for the Review of Instructed Drugs. The criteria not only regulated the active ingredients， dosage forms， indications， usage and dosage， side effects， matters needing attention and warnings of instructed drugs， but also stipulated the requirements for labeling， instructions and outer-of-the-box printing of instructed drugs. Taiwan area had also established a mechanism for evaluating drug conversion to expand the variety range of prescription drugs converted to OTC drugs， and had equipped a series of supporting measures to reduce the safety risks arising from drug conversion. In 2016， Taiwan area also formulated the Format and Relevant Standards for Outer-of-the-Box of Generic Western OCT Drug， and revised the drug instructions and the outer-of-the-box. The format was more standardized and the terminology was easier to understand， which made it easier for the public to read. It is suggested that mainland China should refer to the experience of Taiwan area， set up special registration channels for OTC drugs and simplify the requirements for examination and approval， pay attention to and improve the matching measures for the conversion of prescription drugs to OTC drugs， encourage brand building and improve intelligibility of OTC drug instructions， so as to build an effective OTC drug management system.

A comparison of curriculum design for undergraduate education of rehabilitation therapy in mainland China and Taiwan area / 中华医学教育探索杂志

Undergraduate education started late in rehabilitation medicine in mainland China.At present,there are some shortcomings in current undergraduate education for rehabilitation medicine in mainland China,mainly due to the shortage of teachers,the poor pertinence of professional subjects,the broad and superficial knowledge,and the lack of close connection with the necessary professional knowledge of rehabilitation technologies.The Department of Rehabilitation in Taiwan starts its undergraduate education earlier.The curriculum has been sub-professionally oriented.Its subjects are highly targeted and detailed in content.At the same time,it emphasizes forward-looking education such as "statistics".In view of this,the mainland colleges and universities should standardize the undergraduate education of rehabilitation therapies,strengthen the training of professional teachers,pay attention to the cross-mutualism of theory and practice in the teaching plan,enrich the number of professional courses,the appropriate introduction of teaching methods of scientific research,standardize the teaching management system.

Experience and Enlightenment of Drug Price Regulation in Germany,Japan and Taiwan Area of China / 中国药房

OBJECTIVE:To provide reference for improving the drug price regulation policy in China. METHODS:Literature research,system comparison and other methods were used to summarize the commonalities and characteristics of drug price regula-tion policy in Germany,Japan and Taiwan area of China,and the successful experience was learned. RESULTS & CONCLU-SIONS:Drug price management in Germany,Japan and Taiwan area of China has their own characteristics. Germany conducted reference price system and new drug pricing mechanism,which was the first country to introduce the reference price system. Japan granted price premiums to innovative drugs,decreased pricing for generic drugs and adjusted drug price again. And Taiwan area of China classified and grouped differential pricing to encourage competition negotiation and regularly investigated drug prices and pric-ing. Germany,Japan and Taiwan area regard medicare pay price as core of drug price management,adopt comprehensive means to regulate the drug price,and pay attention to the monitoring and regular adjustment of market price as well. Price negotiation,phar-macoeconomics and multiple pricing methods are broadly used. Value-based drug pricing system is new trend of price policy re-form. It can be used for reference to improve the drug price regulation system in China.

Comparision of Relief Fund System for Adverse Drug Reactions in Japan and Taiwan Area and the En-lightenment to China / 中国药房

OBJECTIVE:To provide reference for constructing relief fund system for adverse drug reactions(ADR)in China. METHODS:Referring to the ADR damage relief system in Japan and Taiwan area of China,comparative study was conducted from aspects of the legal basis of the fund establishment,the nature of the authority,financing sources and ratio,relief efforts,etc. And rationalization suggestions were put forward for constructing the relief fund system for ADR in China. RESULTS & CONCLU-SIONS:The ADR damage relief fund system of Japan and Taiwan area of China was established by the law. However,due to dif-ferent administrative system,financing sources and ratio,and relief efforts,there were some similarities (setting related laws, showing similarities in the partnerships between authorities and its health departments)and differences(the nature of fund authori-ties were independent administrative body in Japan,independent corporation in Taiwan area of China and so on)in the elements of the financing model. When constructing the ADR relief fund system,China should accelerate the relevant legislation;the govern-ment should reasonably arrange fund management agency,gradually establish ADR damage relief fund step by step,enhance the public awareness of ADR damage relief fund and establish diversified financing modes with enterprise-based payment.

Comparison on the Licensed Pharmacists in Hong Kong,Macao,Taiwan and Mainland of China / 中国药房

OBJECTIVE:To provide references for the supervisors of licensed pharmacists and other correlative personnel in mainland of China.METHODS:The related information on the licensed pharmacists in Hong Kong,Macao,Taiwan and mainland of China were compared and analyzed.RESULTS&CONCLUSION:The licensed pharmacists in Hong Kong,Macao,Taiwan are different from those in the mainland of China in terms of the legal bases for management,the control agency,classification and numbers,distribution,qualifications for access,education and continuing education etc.The mainland of China can draw merits from Hong Kong,Macao and Taiwan to further perfect its management on the licensed pharmacists.